Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA5-12138 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Anti-Luteinizing Hormone Monoclonal Antibody (LH01)
- Antibody type
- Monoclonal
- Antigen
- Purifed from natural sources
- Description
- MA5-12138 targets Luteinizing Hormone in IHC (P) applications and shows reactivity with Human samples. The MA5-12138 immunogen is purified human LH-beta.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- LH01
- Vial size
- 500 µL
- Concentration
- 0.2 mg/mL
- Storage
- 4° C
Submitted references A high-throughput analysis of the IDH1(R132H) protein expression in pituitary adenomas.
Activation and regulation of endogenous retroviral genes in the human pituitary gland and related endocrine tumours.
Clinicopathological investigation of vascular endothelial growth factor and von Hippel-Lindau gene-related protein expression in immunohistochemically negative pituitary adenoma--possible involvement in tumor aggressiveness.
Incidence, hormonal distribution and postoperative follow up of atypical pituitary adenomas.
Transsphenoidal microsurgical results of female patients with prolactinomas.
KIT protein expression and mutational status of KIT gene in pituitary adenomas.
Casar-Borota O, Øystese KA, Sundström M, Melchior L, Popovic V
Pituitary 2016 Aug;19(4):407-14
Pituitary 2016 Aug;19(4):407-14
Activation and regulation of endogenous retroviral genes in the human pituitary gland and related endocrine tumours.
Buslei R, Strissel PL, Henke C, Schey R, Lang N, Ruebner M, Stolt CC, Fabry B, Buchfelder M, Strick R
Neuropathology and applied neurobiology 2015 Feb;41(2):180-200
Neuropathology and applied neurobiology 2015 Feb;41(2):180-200
Clinicopathological investigation of vascular endothelial growth factor and von Hippel-Lindau gene-related protein expression in immunohistochemically negative pituitary adenoma--possible involvement in tumor aggressiveness.
Shimoda Y, Ogawa Y, Watanabe M, Tominaga T
Endocrine research 2013;38(4):242-50
Endocrine research 2013;38(4):242-50
Incidence, hormonal distribution and postoperative follow up of atypical pituitary adenomas.
Yildirim AE, Divanlioglu D, Nacar OA, Dursun E, Sahinoglu M, Unal T, Belen AD
Turkish neurosurgery 2013;23(2):226-31
Turkish neurosurgery 2013;23(2):226-31
Transsphenoidal microsurgical results of female patients with prolactinomas.
Ikeda H, Watanabe K, Tominaga T, Yoshimoto T
Clinical neurology and neurosurgery 2013 Sep;115(9):1621-5
Clinical neurology and neurosurgery 2013 Sep;115(9):1621-5
KIT protein expression and mutational status of KIT gene in pituitary adenomas.
Casar-Borota O, Fougner SL, Bollerslev J, Nesland JM
Virchows Archiv : an international journal of pathology 2012 Feb;460(2):171-81
Virchows Archiv : an international journal of pathology 2012 Feb;460(2):171-81
No comments: Submit comment
No validations: Submit validation data